Crossmark

Optimal application of stereotactic body radiotherapy and radiofrequency ablation treatment for different multifocal hepatocellular carcinoma lesions in patients with Barcelona Clinic Liver Cancer stage A4–B1: a pilot study

Crossref DOI link: https://doi.org/10.1186/s12885-021-08897-z

Published Online: 2021-10-30

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Feiqian

Numata, Kazushi https://orcid.org/0000-0003-4671-4431
Takeda, Atsuya

Ogushi, Katsuaki

Fukuda, Hiroyuki

Nihonmatsu, Hiromi

Hara, Koji

Chuma, Makoto

Tsurugai, Yuichirou

Maeda, Shin
License Information

Text and Data Mining valid from 2021-10-30

Version of Record valid from 2021-10-30
More Information

Article History

Received: 16 December 2020

Accepted: 20 October 2021

First Online: 30 October 2021

Declarations

:

: The data collection and analysis of all selected patients and lesions in our retrospective study were approved by the institutional review board of Yokohama City University Medical Center (approval number: B200300052) and were in compliance with the principles of the Declaration of Helsinki. Informed consent to participate in the study were obtained from all subjects by opt-out style in Yokohama City University Medical Center.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below